Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 04:00PM ET
46.65
Dollar change
+0.65
Percentage change
1.41
%
IndexRUT P/E90.08 EPS (ttm)0.52 Insider Own18.88% Shs Outstand19.94M Perf Week4.36%
Market Cap932.07M Forward P/E57.95 EPS next Y0.81 Insider Trans-5.21% Shs Float16.21M Perf Month12.09%
Income10.52M PEG6.01 EPS next Q0.19 Inst Own78.69% Short Float7.32% Perf Quarter18.28%
Sales64.67M P/S14.41 EPS this Y34.01% Inst Trans3.69% Short Ratio11.04 Perf Half Y18.91%
Book/sh8.86 P/B5.27 EPS next Y22.59% ROA5.73% Short Interest1.19M Perf Year8.39%
Cash/sh5.43 P/C8.59 EPS next 5Y15.00% ROE6.16% 52W Range32.69 - 52.69 Perf YTD4.25%
Dividend Est.- P/FCF54.80 EPS past 5Y-0.55% ROI5.92% 52W High-11.46% Beta0.67
Dividend TTM0.18 (0.39%) Quick Ratio8.81 Sales past 5Y15.04% Gross Margin75.14% 52W Low42.70% ATR (14)1.71
Dividend Ex-DateApr 26, 2024 Current Ratio8.81 EPS Y/Y TTM1.56% Oper. Margin14.87% RSI (14)57.30 Volatility2.66% 3.87%
Employees197 Debt/Eq0.01 Sales Y/Y TTM18.86% Profit Margin16.26% Recom1.00 Target Price53.67
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-2.46% Payout49.31% Rel Volume0.97 Prev Close46.00
Sales Surprise5.77% EPS Surprise5.26% Sales Q/Q16.22% EarningsApr 03 AMC Avg Volume107.44K Price46.65
SMA204.31% SMA507.61% SMA20010.37% Trades Volume103,593 Change1.41%
Date Action Analyst Rating Change Price Target Change
May-09-23Initiated BTIG Research Buy $55
Oct-26-21Upgrade Craig Hallum Hold → Buy $65 → $53
Jan-12-21Downgrade Craig Hallum Buy → Hold
Oct-16-20Initiated Raymond James Outperform $95
Sep-08-20Initiated Oppenheimer Outperform $79
Jan-06-20Initiated Craig Hallum Buy $40
Apr-12-24 01:53PM
Apr-08-24 09:06AM
Apr-04-24 09:27AM
08:30AM
06:34AM
06:24AM Loading…
06:24AM
Apr-03-24 08:53PM
05:32PM
05:20PM
04:34PM
04:21PM
Apr-02-24 07:24AM
Mar-20-24 04:06PM
Mar-13-24 08:30AM
Mar-05-24 05:01PM
08:30AM Loading…
08:30AM
Feb-23-24 05:14AM
Feb-15-24 08:30AM
Feb-13-24 09:15AM
Feb-06-24 08:30AM
Feb-05-24 11:30PM
09:35AM
Jan-30-24 08:30AM
Jan-11-24 09:55AM
Jan-09-24 08:30AM
Jan-05-24 03:02AM
Jan-04-24 08:42AM
06:54AM
Jan-03-24 11:26PM
09:51PM
04:13PM Loading…
04:13PM
04:06PM
04:05PM
Jan-02-24 05:27PM
Dec-29-23 08:55AM
Dec-20-23 08:30AM
Dec-06-23 03:04AM
Nov-14-23 08:00AM
Nov-08-23 08:30AM
Nov-03-23 07:03PM
Oct-31-23 08:30AM
Oct-26-23 12:29PM
10:07AM
Oct-25-23 06:36PM
05:23PM
04:06PM
Oct-11-23 04:06PM
Sep-21-23 08:30AM
Sep-07-23 08:30AM
Aug-24-23 08:30AM
Aug-15-23 08:30AM
Jul-18-23 06:53AM
Jul-13-23 12:06PM
08:30AM
Jul-09-23 10:56AM
Jul-07-23 07:57AM
Jul-06-23 05:25PM
04:13PM
04:06PM
Jul-03-23 12:20PM
Jun-25-23 05:56PM
Jun-21-23 08:00PM
04:06PM
Jun-20-23 08:00AM
May-29-23 06:31PM
May-27-23 09:45AM
May-10-23 08:30AM
Apr-26-23 08:00PM
01:40PM
Apr-20-23 10:12AM
Apr-19-23 10:32AM
Apr-18-23 08:30AM
Apr-07-23 10:45PM
09:55AM
Apr-05-23 05:25PM
04:06PM
Mar-31-23 11:58AM
Mar-30-23 08:30AM
Mar-29-23 07:11AM
Mar-28-23 08:30AM
Mar-22-23 04:23AM
Mar-21-23 04:06PM
Mar-17-23 11:17AM
Mar-16-23 08:30AM
Mar-15-23 08:30AM
Mar-09-23 08:30AM
Mar-07-23 08:30AM
Feb-28-23 08:30AM
Feb-16-23 08:30AM
Feb-09-23 08:30AM
Jan-30-23 05:17AM
Jan-17-23 06:39AM
Jan-12-23 11:14AM
08:30AM
Jan-11-23 06:14PM
Jan-10-23 07:45AM
Jan-09-23 06:06AM
Jan-04-23 05:25PM
04:06PM
01:48PM
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The firm operates through the Software and Services segment. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WOLTOSZ WALTER SDirectorApr 01 '24Sale39.9420,000798,8673,600,195Apr 02 04:32 PM
WOLTOSZ WALTER SDirectorMar 01 '24Sale41.4120,000828,2403,620,195Mar 05 04:22 PM
WOLTOSZ WALTER SDirectorFeb 02 '24Sale37.641,05539,7103,640,195Feb 05 05:04 PM
WOLTOSZ WALTER SDirectorFeb 01 '24Sale38.0218,945720,2373,641,250Feb 05 05:04 PM
Paglia John KennethDirectorJan 04 '24Sale43.741,00043,7402,097Jan 04 06:37 PM
WOLTOSZ WALTER SDirectorJan 02 '24Sale44.4620,000889,2003,659,403Jan 04 06:36 PM
DiBella John Anthony IIBusiness Unit PresidentDec 22 '23Sale45.165,411244,36174,429Dec 26 04:31 PM
WOLTOSZ WALTER SDirectorDec 05 '23Sale38.557,050271,7783,764,403Dec 05 06:04 PM
WOLTOSZ WALTER SDirectorDec 04 '23Sale38.6721,802843,0833,771,453Dec 05 06:04 PM
WOLTOSZ WALTER SDirectorDec 01 '23Sale38.8031,1481,208,6123,793,255Dec 05 06:04 PM
Paglia John KennethDirectorNov 08 '23Sale35.251,00035,2503,097Nov 09 04:19 PM
WOLTOSZ WALTER SDirectorNov 02 '23Sale34.602,72094,1123,777,911Nov 03 04:04 PM
WOLTOSZ WALTER SDirectorNov 01 '23Sale34.3857,2801,969,5233,780,631Nov 03 04:04 PM
FREDERICK WILLIAM WCFOOct 24 '23Option Exercise37.892258,5252,100Oct 27 04:09 PM
LaVange LisaDirectorJul 27 '23Sale49.2999248,8965,616Jul 31 04:10 PM
Paglia John KennethDirectorJul 13 '23Sale46.451,20055,7402,644Jul 17 05:15 PM
WOLTOSZ WALTER SDirectorJun 29 '23Sale42.883,754160,9723,836,458Jun 30 04:07 PM
WOLTOSZ WALTER SDirectorJun 28 '23Sale43.0716,246699,7153,840,212Jun 30 04:07 PM
WOLTOSZ WALTER SDirectorMay 30 '23Sale46.0520,000921,0743,856,458May 31 04:28 PM
WOLTOSZ WALTER SDirectorApr 26 '23Sale41.5220,000830,4413,875,739Apr 27 05:16 PM